期刊文献+

持续小剂量化疗对A549肺癌生长及VE-Cadherin的影响 被引量:6

Effect of Low-dose Metronomic Chemotherapy on Growth Rate and VE-Cadherin of A549 Pulmonary Adenocarcinoma in Athymic Mice
下载PDF
导出
摘要 目的检测不同剂量环磷酰胺化疗后,荷A549肺腺癌裸鼠皮下肿瘤生长情况及肿瘤组织中VE-Cadherin的表达。方法右季肋部皮下注射A549细胞悬液,建立荷A549肺腺癌裸鼠模型,分为三组,分别给予持续小剂量(Low-Dose Metronomic,LDM)CTX(环磷酰胺)、最大耐受剂量(MaximumTolerable Dose,MTD)CTX和0.9%氯化钠溶液化疗,每周测量肿瘤体积,21天治疗结束取皮下肿瘤组织,以免疫组织化学SP法检测三组裸鼠皮下肿瘤组织中VE-Cadherin的表达,以RT-PCR法检测癌组织中VE-Cadherin基因含量。结果持续小剂量组肿瘤生长明显慢于大剂量组和对照组,VE-Cadherin表达及基因含量显著低于大剂量组和对照组(P<0.05)。结论持续小剂量化疗可以使癌组织中VE-Cadherin表达下调,抑制肿瘤血管生成,从而持续抑制肿瘤生长。 Objective To investigate the growth rate and the expression of VE-Cadherin of tumor graft of the human pulmonary adenocarcinoma in nude mouse after chemotherapy with different dose of CTX.Methods Eighteen nude mice were subcutanously injected under the anterior right leg with cultured A549 cell suspend fluid.All the nude mice were devided into 3 groups.They were separately accepted the treatment of LDM CTX,MTD CTX and 0.9%NS.The volume of tumors were measured every week by sliding caliper.All nude mice were killed on the 21th day after treatment,then the tumors were taken out.Immunohistochemistry(Strepatacidin peroxidase System for Immunohistological Staining)was used to detect the expressions of VE-Cadherin and RT-PCR was used to detect the content of VE-Cadherin gene in the tumor tissues from 18 cases of nude mice.Results The growth rate,expressions of VE-Cadherin and content of VE-Cadherin gene in LDM group were significantly lower than that either in MTD group or in control group(P0.05).Conclusion The Low-Dose Metronomic chemotherapy can down-regulate the level of VE-Cadherin and suppress the angiogenesis of tumor consequently then suppress the growth of tumor.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第6期624-627,共4页 Cancer Research on Prevention and Treatment
基金 重庆市卫生局资助项目(200453) 重庆市医学特色专科建设项目资金资助项目
关键词 化疗 小剂量 肺癌 VE-CADHERIN 逆转录聚合酶链反应 Chemotherapy Low dose Lung cancer VE-Cadherin RT-polymerase chain reaction
  • 相关文献

参考文献11

  • 1Bertolini F, Paul S, Mancuso P, et al. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothe- lial progenitor cells[J]. Cancer Res,2003, 63(15) :4342-4346.
  • 2Folkman J. Tumor angiogenesis: therapeutic implications[J]. N Engl J Med, 1971, 285(21): 1182-1186.
  • 3张明川,梅同华.抗肺癌血管生成治疗的进展[J].国际呼吸杂志,2006,26(6):467-470. 被引量:4
  • 4Zhao D, Jiang L, Hahn EW, et al. Continuous Low-dose (metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology[J]. Neopla- sia, 2005,7(7) :678-687.
  • 5Emmenegger U, Man S, Shaked Y,et al. A Comparative anal- ysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens[J]. Cancer Res, 2004,64 ( 11 ) : 3994-4000.
  • 6Wallez Y, Vilgrain I, Huber P. Angiogenesis: The VE-ead- herin switch[J]. Trends Cardiovasc Med,2006,16(2) :55-59.
  • 7Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis[J]. Science, 1997, 275 (5302) : 964-967.
  • 8Hunting CB, Noort WA, Zwaginga JJ,et al. Circulating endo- thelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization[J]. Vox Sang, 2005,88(1) : 1-9.
  • 9李欣,崔永生,刘白楠,李一.环磷酰胺联合卡介苗对Lewis肺癌小鼠CD4^+CD25^+Treg细胞及效应细胞功能的影响[J].肿瘤防治研究,2008,35(10):694-696. 被引量:3
  • 10Mariani SM. Antiangiogenesis cocktails -stirred or shaken? [J]. MedGenMed,2004, 6(4): 21.

二级参考文献50

  • 1汲振余,李肖蕖,禹丽娜,赵立群,张聚真,裘一兵,张亚冰,裘宋良,杨观瑞.野生型抑癌基因PTEN真核表达载体的构建及鉴定[J].郑州大学学报(医学版),2005,40(6):1024-1028. 被引量:4
  • 2李祥勇,林观平,周克元.抑癌基因PTEN与细胞凋亡关系的研究进展[J].广东医学院学报,2005,23(6):676-678. 被引量:6
  • 3陈忠华.野生型INK4a基因转染对肺腺癌A549细胞放疗敏感性的调控[J].第三军医大学学报,2006,28(8):785-787. 被引量:1
  • 4李欣,崔永生,王炎,郑晓辉,李一.CD4^+ CD25^+调节性T细胞在Lewis肺癌移植鼠中的检测及临床意义[J].现代肿瘤医学,2007,15(4):454-457. 被引量:10
  • 5Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) : breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995, 155(3):1151-1164.
  • 6Curiel TJ. Tregs and rethinking cancer immunotherapy[J]. J Clin Invest, 2007, 117(5): 1167-1174.
  • 7Proietti E, Greco G, Garrone B, et al. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice[J]. J Clin Invest, 1998,101 (2) : 429-441.
  • 8Taieb J, Chaput N, Schartz N, et al. Chemoirnmunotherapy of tumors: cyelophosphamide synergizes with exosome based vaccines[J]. J Immunol, 2006,176(5):2722-2729.
  • 9Raimondi G, Turner MS, Thomson AW, et al. Naturally occurring regulatory T cells: recent insights in health and disease [J]. Crit Rev Immunol,2007,27(1):61-95.
  • 10Matar P, Gonzalez AD, Gonzalez AD, et al. Mechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide[J]. Eur J Cancer, 2000, 36(8) : 1060-1066.

共引文献6

同被引文献51

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部